| Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718) |
|---|
| 02/23/2005 | CN1583745A Amino biological pterin derivative and pharmaceutical use thereof |
| 02/23/2005 | CN1190437C Pteridine compounds for treatment of psoriasis |
| 02/22/2005 | US6858731 Process for the preparation of pure stereoisomers of tetrahydrofolic acid esters salts and tetrahydrofolic acid by fractionated crystallization of tetrahydrofolic acid esters salts |
| 02/22/2005 | US6858612 Use of tetrahydropteridine derivatives as no synthase inhibitors |
| 02/17/2005 | WO2005014594A1 Process for the purification of riboflavin |
| 02/10/2005 | US20050033049 Heterocyclic nitrogen compounds such as 1-(5-(5-Chlorothiophen -2-yl)-isoxazol-3-ylmethyl)-1H-indole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide, used as anticoagulants for prophylaxis of cardiovascular disorders |
| 02/09/2005 | EP1504010A1 Vitamin-mitomycin conjugates |
| 02/02/2005 | CN1187395C Bulk coloured high polymer organic material containing pyrimido-pteridine or its mixture |
| 02/01/2005 | US6849628 Synthetic diastereoisomers of leucovorin; anticancer agents |
| 02/01/2005 | US6849270 Releasable linkage and compositions containing same |
| 01/27/2005 | WO2004104005A3 Immunosuppressive effects of pteridine derivatives |
| 01/20/2005 | US20050014761 Antitumor agents; antiancer agents; antiinflammatory agents; autoimmune disease |
| 01/20/2005 | US20050014760 Methods of treating diseases or conditions using dihydropteridinone compounds |
| 01/18/2005 | US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 01/13/2005 | US20050010047 Angiogenesis inhibitors; psoriasis; rheumatic disorders; chronic obstructive pulmonary disease |
| 01/13/2005 | CA2531327A1 Compounds and therapeutical use thereof |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 12/29/2004 | WO2004112793A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 12/29/2004 | CA2523015A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists |
| 12/23/2004 | WO2004042002A3 Compounds for modulating rna interference |
| 12/23/2004 | US20040259878 Noninvasive monitoring tumor tissue concentration of an anticarcinogenic agent in real time using magnetic resonance spectroscopy of these nontoxic compounds to determine the sensitivity of or resistance of a tumor to methotrexate; predicting the efficacy of methotrexate therapy and planning strategy |
| 12/22/2004 | EP1488793A1 PREVENTIVES OR REMEDIES FOR DISEAES CAUSED BY eNOS EXPRESSION |
| 12/14/2004 | US6831175 Such as N,N-dimethyl-N-(2-((5-((E)-2-pyridin-4-ylvinyl) pyridin-3-yl)oxy)ethyl)amine |
| 12/08/2004 | EP1484061A1 Drugs containing riboflavin-type compounds |
| 12/07/2004 | US6828323 Isoalloxazine derivatives to neutralize biological contaminants |
| 12/07/2004 | CA2154668C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 12/02/2004 | WO2004104005A2 Immunosuppressive effects of pteridine derivatives |
| 12/02/2004 | US20040242631 PI-3 kinase inhibitor prodrugs |
| 12/02/2004 | US20040242582 diagnostic agent comprising a contrast agent for use in medical imaging conjugated with non-peptide folic acid analog |
| 12/02/2004 | CA2526651A1 Immunosuppressive effects of pteridine derivatives |
| 12/01/2004 | CN1551881A Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 11/25/2004 | WO2004101554A1 New indole derivatives as factor xa inhibitors |
| 11/25/2004 | WO2004100960A2 Anti-inflammatory phosphonate compounds |
| 11/25/2004 | WO2004034972A3 Compounds, compositions, and methods |
| 11/25/2004 | US20040236084 2-Aminopyridine substituted heterocycles |
| 11/25/2004 | CA2526066A1 New indole derivatives as factor xa inhibitors |
| 11/24/2004 | EP1479682A1 Immunosuppressive effects of pteridine derivatives |
| 11/24/2004 | EP1479677A1 New indole derivatives as factor xa inhibitors |
| 11/24/2004 | EP1478647A1 (6s)-5,6,7,8-tetrahydrofolic acid production process |
| 11/24/2004 | EP1411949A4 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 11/18/2004 | US20040229870 Certain alkylene diamine-substituted heterocycles |
| 11/17/2004 | CN1547486A Antibodies to OPGL |
| 11/17/2004 | CN1547472A Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
| 11/17/2004 | CN1546491A Pteridine derivatives with nitric oxide synthase inhibitor function |
| 11/11/2004 | WO2004096287A2 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds |
| 11/11/2004 | WO2004096286A2 Antiviral phosphonate analogs |
| 11/11/2004 | WO2004096236A2 Immunomodulator phosphonate conjugates |
| 11/11/2004 | WO2004096235A2 Anti-cancer phosphonate analogs |
| 11/11/2004 | US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 11/11/2004 | US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement |
| 11/11/2004 | CA2523083A1 Antiviral phosphonate analogs |
| 11/11/2004 | CA2519840A1 Anti-cancer phosphonate analogs |
| 11/10/2004 | EP1474147A1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
| 11/10/2004 | EP1373225A4 Process for coupling amino acids to an antifolate scaffold |
| 11/04/2004 | WO2004094427A1 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same |
| 11/04/2004 | WO2004071463A3 Fluoromethotrexates and uses therefor |
| 11/04/2004 | CA2522538A1 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same |
| 11/03/2004 | CN1543465A Novel heterocyclic compounds as selective bacterial DHFR inhibitors and their uses thereof |
| 10/21/2004 | WO2004089925A1 Pi-3 kinase inhibitor prodrugs |
| 10/21/2004 | WO2004089889A2 Method for the production of riboflavin of modification b/c in granular form |
| 10/21/2004 | US20040209889 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 10/21/2004 | DE10317051A1 Verfahren zur Herstellung von Riboflavin der Modifikation B/C in Granulatform A process for the preparation of riboflavin of modification B / C in granular form |
| 10/21/2004 | CA2521633A1 Method for the production of riboflavin of modification b/c in granular form |
| 10/21/2004 | CA2518916A1 Pi-3 kinase inhibitor prodrugs |
| 10/20/2004 | EP1467994A1 Pteridine derivatives, method for the production thereof, and use thereof |
| 10/19/2004 | US6806272 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 10/14/2004 | US20040204420 Compounds for modulating RNA interference |
| 10/13/2004 | EP1466607A1 Compositions for the treatment of primary and metastatic neoplastic diseases using arsenic compounds in combination with all-trans retinoic acid |
| 10/07/2004 | US20040198738 Preventives or remedies for diseaes caused by enos expression |
| 10/07/2004 | US20040197421 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/07/2004 | US20040197420 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 09/30/2004 | DE10202468A1 Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung Pteridine derivatives, processes for their preparation and their use |
| 09/29/2004 | EP1144412B1 Immunosuppressive effects of pteridine derivatives |
| 09/29/2004 | CN1533277A Preventives or remedies for diseases caused by e NOS expression |
| 09/14/2004 | US6790827 Bioconjugates and delivery of bioactive agents |
| 09/10/2004 | WO2004076454A1 Dihydropteridinones, method for the production and use thereof in the form of drugs |
| 09/09/2004 | US20040176380 Antiproliferative agents; specific cell cycle kinases inhibitors |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/26/2004 | WO2004071463A2 Fluoromethotrexates and uses therefor |
| 08/25/2004 | EP1448202A1 Combination of a pde4 or pde3/4 inhibitor and an anti-rheumatic drug |
| 08/19/2004 | WO2004009036A3 Compounds compositions and methods |
| 08/19/2004 | US20040161475 Anticancer, antitumor agents; ssynergistic mixtures with retinoic acid; olid tumors |
| 08/17/2004 | US6777237 Bioconjugate comprises the bioactive agent and an organocobalt complex |
| 08/17/2004 | US6776976 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/11/2004 | EP1443931A1 Methods for treating neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicaments |
| 08/05/2004 | WO2004065378A1 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation |
| 08/05/2004 | CA2512646A1 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | US20040147524 Methods of using dihydropteridinones |
| 07/29/2004 | US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 07/22/2004 | US20040142949 Compounds, compositions, and methods |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 06/30/2004 | EP1432713A2 Fused pyrimidine dhfr inhibitors as antibacterials |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/24/2004 | WO2004005288A3 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 06/23/2004 | CN1154648C Stable crystal salt of 5-methyl tetrahydrofolic acid |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |